The Vanguard Group, Inc. recently announced the acquisition of new stake in R1 RCM Inc. (NASDAQ:RCM). The institutional investor has increased its shareholding in the Healthcare company by 5.44% to 17.7 million shares with purchase of 0.91 million shares. This fresh investment now brings its stake to 4.22% valued currently at $187.23 million. In addition, BlackRock Fund Advisors raised its holdings by 3.64 million to 15.15 million shares. And Citadel Advisors LLC has lifted its position by 22.85% or 1.89 million shares – to 10.19 million shares.
Currently, there are 417.72M common shares owned by the public and among those 192.41M shares have been available to trade.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Insiders at the company have transacted a total of 34 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 27 of these insider trades were purchases, accounting for 1,575,438 shares. Insider sales of the common stock occurred on 7 occasions, with total insider shares sold totaling 526,078 shares.
The top 3 mutual fund holders in R1 RCM Inc. are iShares Core S&P Mid Cap ETF, Vanguard Total Stock Market ETF, and Vanguard Small Cap Index Fund. iShares Core S&P Mid Cap ETF owns 6.07 million shares of the company’s stock, all valued at over $64.26 million. The company bought an additional 1078.0 shares recently to bring their total holdings to about 1.45% of the shares outstanding. Vanguard Total Stock Market ETF bought 11145.0 shares to see its total holdings expand to 5.94 million shares valued at over $62.84 million and representing 1.42% of the shares outstanding. Vanguard Small Cap Index Fund bought 13152.0 shares to bring its total holdings to over 4.87 million shares at a value of $51.48 million. Vanguard Small Cap Index Fund now owns shares totaling to 1.16% of the shares outstanding.
However, the script later moved the day high at 10.53, up 3.06%. The company’s stock has a 5-day price change of 3.16% and -33.88% over the past three months. RCM shares are trading -4.66% year to date (YTD), with the 12-month market performance down to -3.06% lower. It has a 12-month low price of $9.55 and touched a high of $18.70 over the same period. RCM has an average intraday trading volume of 3.94 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -2.16%, -6.62%, and -29.85% respectively.
Institutional ownership of R1 RCM Inc. (NASDAQ: RCM) shares accounts for 39.08% of the company’s 417.72M shares outstanding. Mutual fund holders own 21.75%, while other institutional holders and individual stakeholders account for 34.10% and 17.57% respectively.
It has a market capitalization of $4.38B and a beta (3y monthly) value of 0.72. The earnings-per-share (ttm) stands at -$0.08. Price movements for the stock have been influenced by the stock’s volatility, which stands at 7.16% over the week and 5.83% over the month.
Analysts forecast that R1 RCM Inc. (RCM) will achieve an EPS of $Royal Caribbean Cruises Ltd. for the current quarter, $123.88 for the next quarter and $Stocks for Type. The lowest estimate earnings-per-share for the quarter is $Rumble Inc. while analysts give the company a high EPS estimate of $Ready Capital Corproation. Comparatively, EPS for the current quarter was $Canadian Imperial Bank of Comme a year ago. Earnings per share for the fiscal year are expected to increase by 252.80%, and 29.23% over the next financial year. EPS should shrink at an annualized rate of -2.50% over the next five years, compared to 24.86% over the past 5-year period.
Looking at the support for the RCM, a number of firms have released research notes about the stock. Morgan Stanley stated their Overweight rating for the stock in a research note on December 15, 2023, with the firm’s price target at $17.50-$17.
